Cargando…
Modified GRAS Score for Prognostic Classification of Adrenocortical Carcinoma: An ENSAT Multicentre Study
Background: Adrenocortical carcinoma (ACC) has an aggressive but heterogeneous behaviour. ENSAT stage and Ki67 proliferation index are used to predict clinical outcome but are limited in distinguishing patients with different risk of disease progress. We aimed to validate the prognostic role of a pr...
Autores principales: | Elhassan, Yasir, Altieri, Barbara, Berhane, Sarah, Cosentini, Deborah, Calabrese, Anna, Haissaguerre, Magalie, Kastelan, Darko, Fragoso, Maria C, Bertherat, Jerome, Baudin, Eric, Haak, Harm, Boudina, Maria, Canu, Letizia, Loli, Paola, Sherlock, Mark, Kimpel, Otilia, Marta, Laganà, Kroiss, Matthias, Arlt, Wiebke, Terzolo, Massimo, Berruti, Alfredo, Deeks, Jonathan, Libe, Rossella, Fassnacht, Martin, Ronchi, Cristina Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265895/ http://dx.doi.org/10.1210/jendso/bvab048.334 |
Ejemplares similares
-
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study
por: Elhassan, Y S, et al.
Publicado: (2021) -
Results of the ADIUVO Study, the First Randomized Trial on Adjuvant Mitotane in Adrenocortical Carcinoma Patients
por: Terzolo, Massimo, et al.
Publicado: (2021) -
Effects of Germline CYP2W1*6 and CYP2B6*6 Single Nucleotide Polymorphisms on Mitotane Treatment in Adrenocortical Carcinoma: A Multicenter ENSAT Study
por: Altieri, Barbara, et al.
Publicado: (2020) -
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study
por: Terzolo, Massimo, et al.
Publicado: (2023) -
What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question
por: Basile, Vittoria, et al.
Publicado: (2021)